Regulation of estrogen receptor α expression in human breast cancer cells by sulforaphane

Journal of Nutritional Biochemistry

Volumn 20, Issue 3, 2009, Pages 195-201

  Ramirez, Marcela Cortes ^a   Singletary, Keith ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Breast cancer; Estrogen receptor; mRNA; Proteasome; Sulforaphane

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; PROTEASOME; SULFORAPHANE;

ARTICLE; BREAST CANCER; CANCER CELL; CATALYSIS; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IC 50; PROTEIN EXPRESSION; RNA TRANSCRIPTION;

BREAST; BREAST NEOPLASMS; CELL LINE; CELL PROLIFERATION; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; HUMANS; LEUPEPTINS; RNA, MESSENGER; THIOCYANATES; TUMOR CELLS, CULTURED;

EID: 58749089692     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.02.002     Document Type: Article

References (43)

1. De Assis S., and Hilakivi-Clarke L. Timing of dietary estrogenic exposures and breast cancer risk. Ann N Y Acad Sci 1089 (2006) 14-35
2. Fowke J.H., Chung F.L., Jin F., Qi D., Cai Q., Conaway C., et al. Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res 63 (2003) 3980-3986
3. Zhang Y., Tang L., and Gonzalez V. Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol Cancer Ther 2 (2003) 1045-1052
4. Bianchini F., and Vainio H. Isothiocyanates in cancer prevention. Drug Metab Rev 36 (2004) 655-667
5. Zhang Y., Kensler T., Cho C., Posner G., and Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci 91 (1994) 3147-3150
6. Fahey J., Zhang Y., and Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci 94 (1997) 10367-10372
7. Singletary K., and MacDonald C. Inhibition of benzo[a]pyrene- and 1,6-dinitropyrene-DNA adduct formation in human mammary epithelial cells by dibenzoylmethane and sulforaphane. Cancer Lett 155 (2000) 47-54
8. Jackson S.J., and Singletary K.W. Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J Nutr 134 (2004) 2229-2236
9. Jackson S.J., and Singletary K.W. Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 25 (2004) 219-227
10. Pledgie-Tracy A., Sobolewski M.D., and Davidson N.E. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 6 (2007) 1013-1021
11. Vaughn S.F., and Berhow M.A. Glucosinolate hydrolysis products from various plants sources: pH effects, isolation and purification. Indust Crops Prod 21 (2005) 193-202
12. Soule H.D., Maloney T.M., Wolman S.R., Peterson W.D., Brenz R., McGrath C.M., et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50 (1990) 6075-6086
13. Lipson K.E., and Baserga R. Transcriptional activity of the human thymidine kinase gene determined by a method using the polymerase chain reaction and an intron-specific probe. Proc Natl Acad Sci U S A 86 (1989) 9774-9777
14. Tian Y., Ke S., Thomas T., Meeker R., and Gallo M. Transcriptional suppression of estrogen receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Steroid Biochem Mol Biol 67 (1998) 17-24
15. Rose'Meyer R.B., Mellick A.S., Garnham B.G., Harrison G.J., Massa H.M., and Griffiths L.R. The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis. Brain Res Brain Res Protoc 11 (2003) 9-18
16. Pappa G., Lichtenberg M., Iori R., Barillari J., Bartsch H., and Gerhauser C. Comparison of growth inhibition profiles and mechanisms of apoptosis induction in human colon cancer cell lines by isothiocyanates and indoles from Brassicaceae. Mutat Res 599 (2006) 76-87
17. Chaudhuri D., Orsulic S., and Ashok B.T. Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells. Mol Cancer Ther 6 (2007) 334-345
18. Shan Y., Sun C., Zhao X., Wu K., Cassidy A., and Bao Y. Effect of sulforaphane on cell growth, G(0)/G(1) phase cell progression and apoptosis in human bladder cancer T24 cells. Int J Oncol 29 (2006) 883-888
19. Shapiro T.A., Fahey J.W., Dinkova-Kostova A.T., Holtzclaw W.D., Stephenson K.K., Wade K.L., et al. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr Cancer 55 (2006) 53-62
20. Ye L., Dinkova-Kostova A.T., Wade K.L., Zhang Y., Shapiro T.A., and Talalay P. Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin Chim Acta 316 (2002) 43-53
21. Xu C., Yuan X., Pan Z., Shen G., Kim J.H., Yu S., et al. Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol Cancer Ther 5 (2006) 1918-1926
22. Reid G., Denger S., Kos M., and Gannon F. Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. Cell Mol Life Sci 59 (2002) 821-831
23. deGraffenried L.A., Hopp T.A., Valente A.J., Clark R.A., and Fuqua S.A. Regulation of the estrogen receptor alpha minimal promoter by Sp1, USF-1 and ERalpha. Breast Cancer Res Treat 85 (2004) 111-120
24. Guo S., and Sonenshein G.E. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway. Mol Cell Biol 24 (2004) 8681-8690
25. Madureira P.A., Varshochi R., Constantinidou D., Francis R.E., Coombes R.C., Yao K.M., et al. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem 281 (2006) 25167-25176
26. Jin C., Moon D., Lee J., Heo M., Choi Y., Lee C., et al. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through downregulation of ERK and Akt in lung adenocarcinoma A-549 cells. Carcinogenesis 28 (2007) 1058-1066
27. Hu R., Khor T., Shen G., Jeong W., Hebbar V., Chen C., et al. Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetables. Carcinogenesis 27 (2006) 2038-2046
28. Jakubikova J., Sedlak J., Mithen R., and Bao Y. Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest, and cell death in Caco-2 cells. Biochem Pharmacol 69 (2005) 1543-1552
29. Oh A.S., Lorant L.A., Holloway J.N., Miller D.L., Kern F.G., and El-Ashry D. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells. Mol Endocrinol 15 (2001) 1344-1359
30. Patten E.J., and DeLong M.J. Temporal effects of the detoxification enzyme inducer, benzyl isothiocyanate: activation of c-Jun N-terminal kinase prior to the transcription factors AP-1 and NFkappaB. Biochem Biophys Res Commun 257 (1999) 149-155
31. Jeong W.S., Kim I.W., Hu R., and Kong A.N. Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line. Pharm Res 21 (2004) 649-660
32. Kwak M., Cho J., Huang B., Shin S., and Kensler T.W. Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells. Free Radic Biol Med 43 (2007) 809-817
33. Hu R., Xu C., Shen G., Jain M., Khor T., GopalKrishnan A., et al. Gene expression profiles induced by cancer chemopreventive isothiocyanates sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2(-/-) mice. Cancer Lett 243 (2006) 170-192
34. Kwak M.K., Huang B., Chang H., Kim J.A., and Kensler T.W. Tissue specific increase of the catalytic subunits of the 26S proteasome by indirect antioxidant dithiolethione in mice: enhanced activity for degradation of abnormal protein. Life Sci 80 (2007) 2411-2420
35. Pinzone J.J., Stevenson H., Strobl J.S., and Berg P.E. Molecular and cellular determinants of estrogen receptor alpha expression. Mol Cell Biol 24 (2004) 4605-4612
36. Fan M., Nakshatri H., and Nephew K. Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation. Mol Endocrinol 18 (2004) 2603-2615
37. Fan M., Bigsby R., and Nephew K. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI182,780 in ER alpha-positive breast cancer cells. Mol Endocrinol 17 (2003) 356-365
38. Borras C., Gambini J., Gomez-Cabrera M.C., Sastre J., Pallardo F.V., Mann G.E., et al. Genistein, a soy isoflavone, up-regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NFkappaB. Faseb J 20 (2006) 2136-2138
39. Fan S., Meng Q., Auborn K., Carter T., and Rosen E.M. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 94 (2006) 407-426
40. Swami S., Krishnan A.V., and Feldman D. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res 6 (2000) 3371-3379
41. Martin M.B., Angeloni S.V., Garcia-Morales P., Sholler P.F., Castro-Galache M.D., Ferragut J.A., et al. Regulation of estrogen receptor-alpha expression in MCF-7 cells by taxol. J Endocrinol 180 (2004) 487-496
42. Alao J.P., Lam E.W., Ali S., Buluwela L., Bordogna W., Lockey P., et al. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. Clin Cancer Res 10 (2004) 8094-8104
43. Shah Y.M., Kaul A., Dong Y., Ip C., and Rowan B.G. Attenuation of estrogen receptor alpha (ERalpha) signaling by selenium in breast cancer cells via downregulation of ERalpha gene expression. Breast Cancer Res Treat 92 (2005) 239-250